nevadensin has been researched along with diosmetin in 1 studies
Studies (nevadensin) | Trials (nevadensin) | Recent Studies (post-2010) (nevadensin) | Studies (diosmetin) | Trials (diosmetin) | Recent Studies (post-2010) (diosmetin) |
---|---|---|---|---|---|
40 | 0 | 25 | 187 | 0 | 140 |
Protein | Taxonomy | nevadensin (IC50) | diosmetin (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 0.14 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 2.437 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 3 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.029 | |
Inositol polyphosphate multikinase | Homo sapiens (human) | 7.2 | |
Aurora kinase B | Homo sapiens (human) | 3.86 | |
Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 0.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goettert, M; Koch, P; Laufer, S; Merfort, I; Schattel, V | 1 |
1 other study(ies) available for nevadensin and diosmetin
Article | Year |
---|---|
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
Topics: Animals; Flavonoids; Humans; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase 14; Models, Molecular; Protein Kinase Inhibitors; Structure-Activity Relationship | 2010 |